439
Views
0
CrossRef citations to date
0
Altmetric
Review

Contemporary management of unipolar depression in the perinatal period

, &
Pages 643-656 | Received 19 Feb 2021, Accepted 06 Apr 2021, Published online: 15 Apr 2021

References

  • Chowdhary N, Sikander S, Atif N, et al., The content and delivery of psychological interventions for perinatal depression by non-specialist health workers in low and middle income countries: a systematic review. Best Pract Res Clin Obstet Gynaecol. 28(1): 113–133. 2014. .
  • Woody CA, Ferrari AJ, Siskind DJ, et al. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord. 2017;219:86–92.
  • Molenaar NM, Kamperman AM, Boyce P, et al., Guidelines on treatment of perinatal depression with antidepressants: an international review. Aust N Z J Psychiatry. 52(4): 320–327. 2018. .
  • Gelaye B, Rondon M, Araya R, et al. Epidemiology of maternal depression, risk factors, and child outcomes in low-income and middle-income countries. Lancet Psychiatry. 2016;3(10):973–982. .
  • WHO. Maternal mental health and child health and development in low and middle income countries. Geneva, Switzerland: WHO-UNFPA meeting; 2008.
  • O’Connor E, Rossom RC, Henninger M, et al., Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US preventive services task force. JAMA. 315(4): 388–406. 2016. .
  • Kim HG, Mandell M, Crandall C, et al. Antenatal psychiatric illness and adequacy of prenatal care in an ethnically diverse inner-city obstetric population. Arch Womens Ment Health. 2006;9(2):103–107. .
  • Brown HK, Qazilbash A, Rahim N, et al. Chronic medical conditions and peripartum mental illness: a systematic review and meta-analysis. Am J Epidemiol. 2018;187(9):2060–2068. .
  • Kurki T, Hiilesmaa V, Raitasalo R, et al. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol. 2000;95(4):487–490. .
  • Gentile S. Managing antidepressant treatment in pregnancy and puerperium. Careful with that axe, Eugene. Expert Opin Drug Saf. 2015;14(7):1011–1014. .
  • Ciesielski TH, Marsit CJ, Williams SM. Maternal psychiatric disease and epigenetic evidence suggest a common biology for poor fetal growth. BMC Pregnancy Childbirth. 2015;15(1):192.
  • Thomas S, Vigil E, Thomas T, et al. Antenatal depressive symptoms and neurodevelopment outcomes in children at 30 months. A study from South India. Front Psychiatry. 2020;11:486175
  • Fuhr DC, Calvert C, Ronsmans C, et al. Contribution of suicide and injuries to pregnancy-related mortality in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Psychiatry. 2014;1(3):213–225. .
  • Khalifeh H, Hunt IM, Appleby L, et al. Suicide in perinatal and non-perinatal women in contact with psychiatric services: 15 year findings from a UK national inquiry. Lancet Psychiatry. 2016;3(3):233–242. .
  • Orsolini L, Valchera A, Vecchiotti R, et al. Suicide during perinatal period: epidemiology, risk factors, and clinical correlates. Front Psychiatry. 2016;7. 10.3389/fpsyt.2016.00138.
  • Surkan PJ, Kennedy CE, Hurley KM, et al. Maternal depression and early childhood growth in developing countries: systematic review and meta-analysis. Bull World Health Organ. 2011 Aug 1;89(8):608–615.
  • Atif N, Krishna RN, Sikander S, et al. Mother-to-mother therapy in India and Pakistan: adaptation and feasibility evaluation of the peer-delivered thinking healthy programme. BMC Psychiatry. 2017;17(1):79. .
  • Ban L, Gibson JE, West J, et al. Association between perinatal depression in mothers and the risk of childhood infections in offspring: a population-based cohort study. BMC Public Health. 2010;10(1):799. .
  • Payne JL, Maguire J. Pathophysiological mechanisms implicated in postpartum depression. Front Neuroendocrinol. 2019;52:165–180. .
  • Hanington L, Ramchandani P, Stein A. Parental depression and child temperament: assessing child to parent effects in a longitudinal population study. Infant Behav Dev. 2010;33(1):88–95.
  • Stein A, Rm P, Sh G, et al., Effects of perinatal mental disorders on the fetus and child. Lancet Lond Engl. 384(9956): 1800–1819. 2014. .
  • A-l S-D, Murray L, Dequae-Merchadou L, et al. A prospective longitudinal study of the impact of early postnatal vs. chronic maternal depressive symptoms on child development. Eur Psychiatry. 2011;26(8):484–489. .
  • Tirumalaraju V, Suchting R, Evans J, et al. Risk of depression in the adolescent and adult offspring of mothers with perinatal depression: a systematic review and meta-analysis. JAMA Network Open. 2020;3(6):e208783. .
  • Patel V, Rodrigues M, Gender DN. Poverty, and postnatal depression: a study of mothers in Goa, India. Am J Psychiatry. 2002;159(1):43–47.
  • Fisher J, Mello MCD, Patel V, et al. Prevalence and determinants of common perinatal mental disorders in women in low- and lower-middle-income countries: a systematic review. Bull World Health Organ. 2012;90(2):139–149H. .
  • Rahman A, Iqbal Z, Harrington R. Life events, social support and depression in childbirth: perspectives from a rural community in the developing world. Psychol Med. 2003;33(7):1161–1167.
  • Vigod SN, Villegas L, Dennis C-L, et al. Prevalence and risk factors for postpartum depression among women with preterm and low-birth-weight infants: a systematic review. BJOG Int J Obstet Gynaecol. 2010;117(5):540–550. .
  • Costas J, Gratacòs M, Escaramís G, et al. Association study of 44 candidate genes with depressive and anxiety symptoms in post-partum women. J Psychiatr Res. 2010;44(11):717–724. .
  • Mehta D, Quast C, Fasching PA, et al. The 5-HTTLPR polymorphism modulates the influence on environmental stressors on peripartum depression symptoms. J Affect Disord. 2012;136(3):1192–1197. .
  • Doornbos B, Daj D-B, Kema IP, et al. The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(7):1250–1254. .
  • Fasching PA, Faschingbauer F, Goecke TW, et al. Genetic variants in the tryptophan hydroxylase 2 gene (TPH2) and depression during and after pregnancy. J Psychiatr Res. 2012;46(9):1109–1117. .
  • Jonas W, Mileva-Seitz V, Girard AW, et al. Genetic variation in oxytocin rs2740210 and early adversity associated with postpartum depression and breastfeeding duration. Genes Brain Behav. 2013;12:681–694.
  • Osborne L, Clive M, Kimmel M, et al. Replication of epigenetic postpartum depression biomarkers and variation with hormone levels. Neuropsychopharmacology. 2016;41(6):1648–1658. .
  • Bloch M, Schmidt PJ, Danaceau M, et al. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry. 2000;157(6):924–930. .
  • Skrundz M, Bolten M, Nast I, et al. Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2011;36(9):1886–1893. .
  • Kroll-Desrosiers AR, Nephew BC, Babb JA, et al. Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year. Depress Anxiety. 2017;34(2):137–146. .
  • Bloch M, Daly RC, Rubinow DR. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry. 2003;44(3):234–246.
  • Deligiannidis KM, Kroll-Desrosiers AR, Mo S, et al. Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression. Psychoneuroendocrinology. 2016;70:98–107.
  • Laurent HK, Ablow JC. A cry in the dark: depressed mothers show reduced neural activation to their own infant’s cry. Soc Cogn Affect Neurosci. 2012;7(2):125–134.
  • Wonch KE, De Medeiros CB, Barrett JA, et al.. Postpartum depression and brain response to infants: differential amygdala response and connectivity. Soc Neurosci. 2016;11(6):600–617.
  • Dadi AF, Miller ER, Bisetegn TA, et al., Global burden of antenatal depression and its association with adverse birth outcomes: an umbrella review. BMC Public Health. 20(1): 173. 2020. .
  • Rochat TJ, Tomlinson M, Bärnighausen T, et al. The prevalence and clinical presentation of antenatal depression in rural South Africa. J Affect Disord. 2011;135(1–3):362–373. .
  • Biaggi A, Conroy S, Pawlby S, et al. Identifying the women at risk of antenatal anxiety and depression: a systematic review. J Affect Disord. 2016;191:62–77.
  • Lee AM, Lam SK, Lau SMSM, et al. Prevalence, course, and risk factors for antenatal anxiety and depression. Obstet Gynecol. 2007;110(5):1102–1112. .
  • Nonacs R, Cohen LS. Postpartum mood disorders: diagnosis and treatment guidelines. J Clin Psychiatry. 1998;59(Suppl 2):34–40.
  • Vliegen N, Casalin S, Luyten P. The course of postpartum depression: a review of longitudinal studies. Harv Rev Psychiatry. 2014;22(1):1–22. .
  • Woolhouse H, Gartland D, Mensah F, et al. Maternal depression from early pregnancy to 4 years postpartum in a prospective pregnancy cohort study: implications for primary health care. BJOG Int J Obstet Gynaecol. 2015;122(3):312–321. .
  • Rahman A, Creed F. Outcome of prenatal depression and risk factors associated with persistence in the first postnatal year: prospective study from Rawalpindi, Pakistan. J Affect Disord. 2007;100(1–3):115–121.
  • Vesga-López O, Blanco C, Keyes K, et al. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry. 2008;65(7):805–815. .
  • Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry. 1993;163(1):27–31.
  • Munk-Olsen T, Laursen TM, Pedersen CB, et al. New parents and mental disorders: a population-based register study. JAMA. 2006;296(21):2582–2589. .
  • Bernstein IH, Rush AJ, Yonkers K, et al. Symptom features of postpartum depression: are they distinct? Depress Anxiety. 2008;25(1):20–26. .
  • Jaeschke RR, Dudek D, Topór-Mądry R, et al. Postpartum depression: bipolar or unipolar? Analysis of 434 Polish postpartum women. Rev Bras Psiquiatr. 2017;39(2):154–159. .
  • Leung SSL, Leung C, Lam TH, et al. Outcome of a postnatal depression screening programme using the Edinburgh Postnatal depression scale: a randomized controlled trial. J Public Health. 2011;33(2):292–301. .
  • Sit DK, Wisner KL. The identification of Postpartum depression. Clin Obstet Gynecol. 2009;52(3):456–468.
  • Harris AL. Barriers to and Facilitators of Perinatal Depression Screening. Nurs Womens Health. 2017;20(6):601–607.
  • Abrams LS, Dornig K, Curran L. Barriers to service use for postpartum depression symptoms among low-income ethnic minority mothers in the United States. Qual Health Res. 2009;19(4):535–551.
  • O’Mahen HA, Flynn HA. Preferences and perceived barriers to treatment for depression during the perinatal period. J Womens Health (Larchmt). 2008;17(8):1301–1309.
  • Mathibe-Neke JM, Rothberg A, Langley G The perception of midwives regarding psychosocial risk assessment during antenatal care. Health SA Gesondheid (Online) [Internet]. 2014 [2019 Oct 22];19:01–09. Available from: http://www.scielo.org.za/scielo.php?script=sci_abstract&pid=S2071-97362014000100005&lng=en&nrm=iso&tlng=en.
  • Legere LE, Wallace K, Bowen A, et al. Approaches to health-care provider education and professional development in perinatal depression: a systematic review. BMC Pregnancy Childbirth. 2017;17(1):239.
  • Bhat A, Grote NK, Russo J, et al. Collaborative care for perinatal depression among socioeconomically disadvantaged women: adverse Neonatal birth events and treatment response. Psychiatr Serv. 2017;68(1):17–24.
  • Mendenhall E, De Silva MJ, Hanlon C, et al. Acceptability and feasibility of using non-specialist health workers to deliver mental health care: stakeholder perceptions from the PRIME district sites in Ethiopia, India, Nepal, South Africa, and Uganda. Soc Sci Med. 2014;118:33–42.
  • Surjaningrum ER, Minas H, Jorm AF, et al. The feasibility of a role for community health workers in integrated mental health care for perinatal depression: a qualitative study from Surabaya, Indonesia. Int J Ment Health Syst. 2018;12(1):27.
  • Steeves-Reece A, Yuan N, Green L. A qualitative study exploring the role of community health workers in promoting maternal postpartum mental health in Nicaragua. J Global Health Rep. 2019;3:e2019089.
  • Jl C, Jm H, Sagovsky R. Development of the 10-item Edinburgh Postnatal depression scale. Br J Psychiat. 1987;150(6):782–786.
  • Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9):509–515.
  • Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8(1):77–100.
  • Radloff LS. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
  • Moraes GPDA, Lorenzo L, Gar P, et al. Screening and diagnosing postpartum depression: when and how? Trends Psychiatry Psychother. 2017;39(1):54–61.
  • Bergink V, Kooistra L, Lambregtse-van Den Berg MP, et al. Validation of the Edinburgh depression scale during pregnancy. J Psychosom Res. 2011;70(4):385–389.
  • Fernandes MC, Srinivasan K, Stein AL, et al. Assessing prenatal depression in the rural developing world: a comparison of two screening measures. Arch Womens Ment Health. 2011;14(3):209–216.
  • Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33. quiz 34-57.
  • Castro E, Couto T, Martins Brancaglion MY, et al. What is the best tool for screening antenatal depression? J Affect Disord. 2015;178:12–17.
  • Van Heyningen T, Honikman S, Tomlinson M, et al. Comparison of mental health screening tools for detecting antenatal depression and anxiety disorders in South African women. Plos One. 2018;13(4):e0193697.
  • Spitzer RL, Williams JB, Gibbon M, et al. The Structured Clinical Interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry. 1992;49(8):624–629.
  • Zubaran C, Foresti K, Schumacher MV, et al. The correlation between postpartum depression and health status. Matern Child Health J. 2010;14(5):751–757.
  • Gjerdingen D, McGovern P, Center B. Problems encountered with using a diagnostic depression interview in a Postpartum depression trial. J Am Board Fam Med. 2011;24(2):187–193.
  • Wing JK, Babor T, Brugha T, et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry. 1990;47(6):589–593.
  • Brugha TS, Wheatley S, Taub NA, et al. Pragmatic randomized trial of antenatal intervention to prevent post-natal depression by reducing psychosocial risk factors. Psychol Med. 2000;30(6):1273–1281.
  • Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 1978;35(7):837–844.
  • Hobfoll SE, Ritter C, Lavin J, et al. Depression prevalence and incidence among inner-city pregnant and postpartum women. J Consult Clin Psychol. 1995;63(3):445–453. .
  • Dama M, Steiner M, Lieshout RV. Thyroid peroxidase autoantibodies and perinatal depression risk: a systematic review. J Affect Disord. 2016;198:108–121.
  • Lowenhoff C, Appleton JV, Davison-Fischer J, et al. NICE guideline for antenatal and postnatal mental health: the health visitor role. J Health Visit. 2017;5(6):290–298. .
  • Payne JL, Meltzer-Brody S. Antidepressant use during pregnancy: current controversies and treatment strategies. Clin Obstet Gynecol. 2009;52(3):469–482.
  • Bérard A, J-p Z, Sheehy O. Sertraline use during pregnancy and the risk of major malformations. Am J Obstet Gynecol. 2015;212(6):795.e1–795.e12.
  • Kornum JB, Nielsen RB, Pedersen L, et al. Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis. Clin Epidemiol. 2010;2:29–36.
  • Jimenez-Solem E, Andersen JT, Petersen M, et al. Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open. 2012;2(3):e001148. .
  • Furu K, Kieler H, Haglund B, et al. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ. 2015;350(apr17 3):h1798. .
  • Gao S-Y, Wu Q-J, Sun C, et al. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med. 2018;16(1):205. .
  • RUguz F. Maternal antidepressant use during pregnancy and the risk of attention-deficit/hyperactivity disorder in children: a systematic review of the current literature. J Clin Psychopharmacol. 2018;38(3):254–259.
  • Morales DR, Slattery J, Evans S, et al. Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations. BMC Med. 2018;16(1):6. .
  • Sujan AC, Öberg AS, Quinn PD, et al. Annual research review: maternal antidepressant use during pregnancy and offspring neurodevelopmental problems – a critical review and recommendations for future research. J Child Psychol Psychiatry. 2019;60(4):356–376. .
  • Grove K, Lewis AJ, Galbally M. Prenatal antidepressant exposure and child motor development: a meta-analysis. Pediatrics. 2018;142(1):e20180356.
  • Prady SL, Hanlon I, Fraser LK, et al., A systematic review of maternal antidepressant use in pregnancy and short- and long-term offspring’s outcomes. Arch Womens Ment Health. 21(2): 127–140. 2018. .
  • Avalos LA, Chen H, Li D-K. Antidepressant medication use, depression, and the risk of preeclampsia. CNS Spectr. 2015;20(1):39–47.
  • Venkatesh KK, Castro VM, Perlis RH, et al. Impact of antidepressant treatment during pregnancy on obstetric outcomes among women previously treated for depression: an observational cohort study. J Perinatol. 2017;37(9):1003–1009. .
  • Zakiyah N, Ter Heijne LF, Bos JH, et al. Antidepressant use during pregnancy and the risk of developing gestational hypertension: a retrospective cohort study. BMC Pregnancy Childbirth. 2018;18(1):187. .
  • Bernard N, Forest J-C, Tarabulsy GM, et al. Use of antidepressants and anxiolytics in early pregnancy and the risk of preeclampsia and gestational hypertension: a prospective study. BMC Pregnancy Childbirth. 2019;19(1):146. .
  • Dandjinou M, Sheehy O, Bérard A. Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case–control study. BMJ Open. 2019;9(9):e025908.
  • Broy P, Bérard A. Gestational exposure to antidepressants and the risk of spontaneous abortion: a review. Curr Drug Deliv. 2010;7(1):76–92.
  • Kjaersgaard MIS, Parner ET, Vestergaard M, et al. Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study. PloS One. 2013;8(8):e72095. .
  • Chang Q, Ma X-Y, Xu X-R, et al. Antidepressant use in depressed women during pregnancy and the risk of preterm birth: a systematic review and meta-analysis of 23 cohort studies. Front Pharmacol. 2020;11:659.
  • Bandoli G, Chambers CD, Wells A, et al. Prenatal antidepressant use and risk of adverse Neonatal outcomes. Pediatrics. 2020;146(1):e20192493. .
  • Nörby U, Forsberg L, Wide K, et al. Neonatal morbidity after maternal use of antidepressant drugs during pregnancy. Pediatrics. 2016;138(5):138. .
  • Ter Horst PGJ, Jansman FGA, Van Lingen RA, et al. Pharmacological aspects of neonatal antidepressant withdrawal. Obstet Gynecol Surv. 2008;63(4):267–279. .
  • Byatt N, Deligiannidis KM, Freeman MP. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand. 2013;127(2):94–114.
  • Ross LE, Grigoriadis S, Mamisashvili L, et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry. 2013;70(4):436–443. .
  • Mitchell J, Goodman J. Comparative effects of antidepressant medications and untreated major depression on pregnancy outcomes: a systematic review. Arch Womens Ment Health. 2018;21(5):505–516. .
  • Committee on Drugs. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Am Acad Pediatr. 2000;105(4 Pt 1):880–887.
  • Ram D, Gandotra S. Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation. Indian J Psychiatry. 2015;57(6):S354–371.
  • Molyneaux E, Howard LM, McGeown HR, et al. Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev. 2014. CD002018. 10.1002/14651858.CD002018.pub2.
  • Grigoriadis S, Eh V, Mamisashvili L, et al. The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry. 2013;74(4):e309–320. .
  • Suri R, Stowe ZN, Hendrick V, et al. Estimates of nursing infant daily dose of fluoxetine through breast milk. Biological Psychiatry. cited 2021 Feb 16. 2002;52:446–451. Available from. 5. https://www.biologicalpsychiatryjournal.com/article/S0006-3223(02)01368-9/abstract
  • Bérard A, Zhao J-P SO, Sheehy O. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec pregnancy cohort. BMJ Open. 2017;7(1):e013372.
  • Tinker SC, Reefhuis J, Bitsko RH, et al. Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997–2011. Birth Defects Res. 2019;111(10):613–620. .
  • Grover S, Avasthi A, Sharma Y. Psychotropics in pregnancy: weighing the risks. Indian J Med Res. 2006;123(4):497–512.
  • Simon GE, Cunningham ML, Davis RL. Outcomes of Prenatal antidepressant exposure. Am J Psychiatry. 2002;159(12):2055–2061.
  • Falterman CG, Richardson CJ. Small left colon syndrome associated with maternal ingestion of psychotropic drugs. J Pediatr. 1980;97(2):308–310.
  • Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354(6):579–587. .
  • Davanzo R, Copertino M, De Cunto A, et al. Antidepressant drugs and breastfeeding: a review of the literature. Breastfeed Med Off J Acad Breastfeed Med. 2011;6(2):89–98. .
  • Ip S, Chung M, Raman G, et al. A summary of the Agency for Healthcare Research and Quality’s evidence report on breastfeeding in developed countries. Breastfeed Med. 2009;4(Suppl 1):S17–30. .
  • Sriraman NK, Melvin K, Meltzer-Brody S, et al. #18: use of antidepressants in breastfeeding mothers. Breastfeed Med. 2015;10(6):290–299. .
  • Hale T. Medications and mothers milk. 16th ed. Plano, TX: Hale Publishing; 2014.
  • Stowe ZN, Cohen LS, Hostetter A, et al. Paroxetine in human breast milk and nursing infants. Am J Psychiatry. 2000;157(2):185–189. .
  • Weissman AM, Levy BT, Hartz AJ, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry. 2004;161(6):1066–1078. .
  • Wisner KL, Perel JM, Peindl KS, et al. Prevention of recurrent postpartum depression: a randomized clinical trial. J Clin Psychiatry. 2001;62(2):82–86. .
  • Wisner KL, Perel JM, Peindl KS, et al. Prevention of postpartum depression: a pilot randomized clinical trial. Am J Psychiatry. 2004;161(7):1290–1292. .
  • Stuart S, Koleva H. Psychological treatments for perinatal depression. Best Pract Res Clin Obstet Gynaecol. 2014;28(1):61–70.
  • Kamalifard M, Yavarikia P, Babapour Kheiroddin J, et al. The effect of peers support on Postpartum depression: a single-blind randomized clinical trial. J Caring Sci. 2013;2(3):237–244. .
  • Steardo L, Caivano V, Sampogna G, et al. Psychoeducational Intervention for Perinatal depression: study protocol of a randomized controlled trial. Front Psychiatry. 2019;10. 10.3389/fpsyt.2019.00055.
  • Nanzer N, Sancho Rossignol A, Righetti-Veltema M, et al. Effects of a brief psychoanalytic intervention for perinatal depression. Arch Womens Ment Health. 2012;15(4):259–268. .
  • Ponting C, Mahrer NE, Zelcer H, et al. Psychological interventions for depression and anxiety in pregnant Latina and Black women in the United States: a systematic review. Clin Psychol Psychother. 2020;27(2):249–265. .
  • Stephens S, Ford E, Paudyal P, et al. Effectiveness of psychological interventions for postnatal depression in primary care: a meta-analysis. Ann Fam Med. 2016;14:463–472.
  • Nisar A, Yin J, Yiping N, et al. Making therapies culturally relevant: translation, cultural adaptation and field-testing of the thinking healthy programme for perinatal depression in China. BMC Pregnancy Childbirth. 2020;20(1):368. .
  • Mulcahy R, Reay RE, Wilkinson RB, et al. A randomised control trial for the effectiveness of group interpersonal psychotherapy for postnatal depression. Arch Womens Ment Health. 2010;13(2):125–139. .
  • Milgrom J, Holt CJ, Gemmill AW, et al. Treating postnatal depressive symptoms in primary care: a randomised controlled trial of GP management, with and without adjunctive counselling. BMC Psychiatry. 2011;11(1):95. .
  • Gureje O, Oladeji BD, Araya R, et al. Expanding care for perinatal women with depression (EXPONATE): study protocol for a randomized controlled trial of an intervention package for perinatal depression in primary care. BMC Psychiatry. 2015;15:136
  • Sikander S, Ahmad I, Atif N, et al. Delivering the Thinking Healthy Programme for perinatal depression through volunteer peers: a cluster randomised controlled trial in Pakistan. Lancet Psychiatry. 2019;6(2):128–139. .
  • Sockol LE. A systematic review of the efficacy of cognitive behavioral therapy for treating and preventing perinatal depression. J Affect Disord. 2015;177:7–21. .
  • Sockol LE. A systematic review and meta-analysis of interpersonal psychotherapy for perinatal women. J Affect Disord. 2018;232:316–328. .
  • Bright KS, Charrois EM, Mughal MK, et al. Interpersonal psychotherapy to reduce psychological distress in Perinatal women: a systematic review. Int J Environ Res Public Health. 2020;17:8421
  • Bleker LS, Milgrom J, Sexton-Oates A, et al. Cognitive behavioral therapy for antenatal depression in a pilot randomized controlled trial and effects on neurobiological, behavioral and cognitive outcomes in offspring 3–7 Years Postpartum: a perspective article on study findings, limitations and future aims. Front Psychiatry. 2020;11. 10.3389/fpsyt.2020.00034.
  • Stein A, Netsi E, Lawrence PJ, et al. Mitigating the effect of persistent postnatal depression on child outcomes through an intervention to treat depression and improve parenting: a randomised controlled trial. Lancet Psychiatry. 2018;5(2):134–144.
  • World Health Organization. Thinking healthy: a manual for psychosocial management of perinatal depression, WHO generic field-trial version 1.0, 2015 [Internet]. World Health Organization; 2015 [cited 2019 Oct 31]. Available from: https://apps.who.int/iris/handle/10665/152936.
  • Curry SJ, Krist AH, Owens DK, US Preventive Services. Task Force. Interventions to prevent Perinatal depression: US preventive services task force recommendation statement. JAMA. 2019;321(6):580–587.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.